Tinea Pedis
56
2
2
45
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
19 trials with published results (34%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
3.6%
2 terminated out of 56 trials
95.7%
+9.2% vs benchmark
41%
23 trials in Phase 3/4
42%
19 of 45 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 45 completed trials
Clinical Trials (56)
Atmospheric Pressure Cold Plasma for Moderate-to-severe Tinea Pedis
Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study
A Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea Pedis
Efficacy of Tropical Sertaconazole Nitrate 2% Vs Clotrimazole 1% for Tinea Pedis
Spread of Dermatophytes Among Families
Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis
A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis
Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis
A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis
Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea Pedis
Safety and Equivalence of a Generic Ciclopirox Olamine Cream Compared to the Reference Ciclopirox Cream 0.77% for the Treatment of Tinea Pedis
A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.
Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet
Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis
A Therapeutic Equivalence Study of Ketoconazole Cream 2%
Non-inferiority Trial of Dapaconazole Versus Ketoconazole
Study With Nåva Foot Cream in Patients With Tinea Pedis Interdigitalis
Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris
Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris
Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot